NASDAQ: ELDN
Eledon Pharmaceuticals Inc Stock Ownership - Who owns Eledon Pharmaceuticals?

Insider buying vs selling

Have Eledon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Davidalexandre C. GrosCEO2026-07-31194,791$3.38
$658.39kSell
Steven PerrinPres2026-07-3172,138$3.38
$243.83kSell

1 of 1

ELDN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELDN insiders and whales buy or sell their stock.

ELDN Shareholders

What type of owners hold Eledon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison10.00%8,124,773$29.41MInsider
Erez Chimovits7.04%5,720,424$20.71MInsider
Novartis Bioventures Ltd5.53%4,493,458$16.27MInsider
Apple Tree Partners II LP5.19%4,218,641$15.27MInsider
Apple Tree Partners II Annex LP4.39%3,568,438$12.92MInsider
Muneer A. Satter2.18%1,771,688$6.41MInsider
Lifesci Index Partners LLC1.31%1,065,867$3.86MInsider
Logos Global Management LP0.45%369,071$1.34MInsider
Bvf Partners L P0.27%220,460$798.07kInsider
Martin D. Williams0.21%168,850$611.24kInsider

1 of 3

ELDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELDN0.06%37.81%Net SellingNet Selling
FULC0.10%55.90%Net SellingNet Buying
AVXL0.04%4.79%Net Buying
TTRX0.00%58.04%Net Buying
ALXO0.08%10.66%Net BuyingNet Selling

Eledon Pharmaceuticals Stock Ownership FAQ

Who owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals (NASDAQ: ELDN) is owned by 0.06% institutional shareholders, 37.81% Eledon Pharmaceuticals insiders, and 62.13% retail investors. Seth Loring Harrison is the largest individual Eledon Pharmaceuticals shareholder, owning 8.12M shares representing 10.00% of the company. Seth Loring Harrison's Eledon Pharmaceuticals shares are currently valued at $29.41M.

If you're new to stock investing, here's how to buy Eledon Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.